XORTX Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TD WATERHOUSE CANADA INC. | 05/12/2026 | 47 | $19 | 100.00% | 0.00% |
| CLEARSTEAD ADVISORS, LLC | 05/06/2026 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| BAADER BANK AKTIENGESELLSCHAFT | 05/08/2026 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
XORTX Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 7 institutional investors and hedge funds held shares of XORTX Therapeutics Inc. The most heavily invested institutionals were:
TD Waterhouse Canada Inc.: 47
TWO SIGMA SECURITIES, LLC: 0
DRW Securities, LLC: 0
ROYAL BANK OF CANADA: 0
Clearstead Advisors, LLC: 0
UBS Group AG: 0
0.00% of XORTX Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 47 shares in the last 24 months. This purchase volume represents approximately $22 in transactions.